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• On average, women were 35.2 years old (SD=10.7), married (62.5%), Caucasian (80.8%), educated 15.1 years (SD=2.5) 
• At baseline, 26.56% (N=51) were diagnosed with PTSD; and 24.87% (N=48) were diagnosed with (‘persistent’) IBS 
• The most common surgical and medical treatments used during follow-up were the same between the 2 groups: 
enterolysis (IBS 10%, No IBS 6%), hysterectomy (IBS 6%, No IBS 9%), antidepressants (IBS 21%, No IBS 23%), 
narcotics (IBS 21%, No IBS 19%) 
Significant co-morbidity between Irritable Bowel Syndrome 
(IBS) and chronic pelvic pain (CPP) has been reported (35-39%). 
IBS affects 10-20% of the general population, and is the most 
common condition diagnosed by gastroenterologists. Patients 
with IBS have abdominal pain and abnormal stool. CPP affects 
12-39% of women and is defined as non-cyclical pain of at least 
6-month duration.  Previous research at UNC has reported a co-
morbidity between IBS with CPP of 35% and has identified 
distinct characteristics between these two groups. It has been 
hypothesized that co-morbid IBS with CPP is associated with 
higher pain report, poorer quality of life and treatment response 
and should be evaluated thoroughly in the treatment of women 
with chronic pelvic pain. 
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To evaluate baseline pain and psychological characteristics, 
clinical pain improvement over time, and effectiveness of 
treatments among CPP patients with and without co-morbid 
IBS. 
Our data show that even though CPP patients with and without IBS are treated very similarly (i.e., medically and 
surgically) and exhibit parallel pain improvement over a 1-year period, those with co-morbid IBS consistently have 
higher pain reports. Therefore, we propose that IBS compounds pelvic pain symptoms, and its evaluation and 
treatment are vital components of pelvic pain treatment in this population. Further research on therapeutic strategies 
targeted at the co-morbidity of IBS among women with CPP is warranted.  
BACKGROUND 
New pelvic pain patients seen at the UNC Pelvic Pain Clinic 
between 2003 and 2006 were approached for participation in our 
study. They were asked to complete a baseline and interval (3, 6, 
9, 12 months) questionnaires assessing pain severity, 
psychological distress, and IBS symptoms. Of the original cohort 
of 293 women, a total of 193 completed at least 2 of the 5 
quarterly IBS questionnaires (Rome II) and were included in the 
analysis. Subjects diagnosed as having IBS at 2 or more time 
points were defined as having ‘persistent IBS’ (N=48). Medical 
and surgical interventions before and during follow-up were 
abstracted from electronic medical records. Clinical pain reports 
were compared between baseline and the average of those from 9 
and 12 months. Student’s t test and partial correlations were 
analyzed using SAS software (SAS Institute Inc, Cary, NC). 
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Table 1: Baseline & Follow-Up 
Characteristics 
IBS mean 
(SD) 
N=48 
No IBS 
mean (SD) 
N=145 
Years of pelvic pain; 
P=0.05 
6.86 
(SD=6.75) 
4.77 
(SD=4.84)  
Average PTSD score 
(0-4); P=0.02 
1.12 
(SD=1.04) 
0.74 
(SD=0.71) 
Average mental health 
(0-100); P=0.03 
39.77 
(SD=10.36) 
43.23 
(SD=9.62)  
Previous surgeries for 
pelvic pain 
1.24 
(SD=1.69)  
1.22 
(SD=1.84)  
Surgeries during 
follow-up 
0.38 
(SD=0.53)  
0.30 
(SD=0.50)  
Previous trauma 
events 
2.17 
(SD=2.42)  
1.54 
(SD=1.73)  
Doctor appointments 
in past 3 months 
5.28 
(SD=4.63)  
4.71 
(SD=4.36)  
Pelvic pain doctor 
appts in past 3 months 
3.93 
(SD=3.68)  
3.65 
(SD=4.25)  
1-Year mean 
catastrohpization (0-6) 
1.71 
(SD=0.14) 
1.42 
(SD=0.08) 
1-Year mean pelvic 
pain dysphoria (1-5) 
2.38 
(SD=0.10) 
2.18 
(SD=0.06) 
Previous hysterectomy 20.83% 
(N=10) 
24.83% 
(N=36) 
Figure 2: Changes in Clinical Pain Reports Over a 1-Year 
Period of Pelvic Pain Patients with & without Co-Morbid IBS
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Figure 1: Differences in Clinical Pain Reports over 1-Year of 
Pelvic Pain Patients with & without Co-Morbid IBS*
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*Values reflect least squared means, controlling for baseline pelvic pain
p=0.02p<0.01
p<0.01
